Search
Close this search box.
MedGeneRx Logo 300x61 REG
Treatment of Chronic Wounds with Autologous Platelet Rich Plasma

Treatment of Chronic Wounds with Autologous Platelet-Rich-Plasma

Abstract

After treatment with platelet-rich plasma, 50% of the wounds had healed, 35.7% had reduced in size and 14.2% were unchanged in terms of area and condition. Recurrencies were not observed during the follow-up period of an average of 34.5 weeks (range 6,5 weeks-52 weeks). Conclusion: The use of autologous platelet-rich plasma should be reserved for treatment of recalcitrant wounds where there is lack of improvement despite treatment of underlying causes and good local wound care.

Source: CLICK HERE – Treatment of Chronic Wounds with Autologous Platelet-Rich-Plasma

We’re here to help your patients and your practice.

Through innovative technology, preparation & training.

Skip to content